SCHERING logo 228 (Fulvicin P G ultramicrocrystalline 125 mg)
Generic Name: griseofulvin
This pill with imprint "SCHERING logo 228" is White, Round and has been identified as Fulvicin P G ultramicrocrystalline 125 mg. It is manufactured by Schering-Plough Corporation.
Fulvicin P/G is used in the treatment of dermatophytosis; tinea corporis; tinea barbae; onychomycosis, toenail; tinea pedis (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Fulvicin P/G ultramicrocrystalline 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- griseofulvin
- Imprint:
- SCHERING logo 228
- Strength:
- ultramicrocrystalline 125 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Schering-Plough Corporation
More about Fulvicin P/G (griseofulvin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antifungals
Consumer resources
Other brands: Grifulvin V, Gris-PEG, Fulvicin U/F
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
